Deep Dive: Page 2

Industry insights from our journalists


  • Photo of exhibition hall floor, HIMSS22 in Orlando, March
    Image attribution tooltip
    Rebecca Pifer/MedTech Dive
    Image attribution tooltip

    The case for hybrid care models

    Telehealth is increasingly being woven into healthcare organizations' future plans, giving hope to proponents of hybrid care models.

    Rebecca Pifer • March 22, 2022
  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images
    Image attribution tooltip

    Threats, obscenities, homicide: Healthcare workers stressed by pandemic face elevated violence

    Millions of healthcare workers across the country are becoming inured to workplace violence, which can range from verbal abuse and threats to physical attacks and even homicide.

    Hailey Mensik • March 9, 2022
  • Medtech, hospitals on alert for cyberattacks after Russia's invasion of Ukraine

    While cybersecurity threats to healthcare and medical devices have grown during the pandemic, the Russia-Ukraine conflict has raised the threat level, putting patient safety at risk.

    Greg Slabodkin • Feb. 28, 2022
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    3 key FDA topics for medtechs in 2022

    While the agency is looking to get back to normal operations this year, COVID-19 is poised to remain a top priority and, once again, thin resources for more traditional work, such as product reviews.

    Ricky Zipp and Greg Slabodkin • Feb. 1, 2022
  • Healthcare workers at Catholic Health's Mercy Hospital in Buffalo, New York, wage a strike.
    Image attribution tooltip
    Permission granted by Communication Workers of America
    Image attribution tooltip

    3 key labor trends for hospitals in 2022

    Hospitals are still grappling with rising turnover, widespread burnout and numerous staff calling in sick nearly two years after the pandemic began. It's unclear when it might get better — or how much worse it could get.

    Hailey Mensik • Jan. 27, 2022
  • Image attribution tooltip
    alvarez via Getty Images
    Image attribution tooltip

    4 key trends for procedure-reliant medtechs in 2022

    Medical device companies likely will face the same challenges this year that they have been dealing with since the pandemic's start, such as procedure volatility and hospital staffing shortages.

    Ricky Zipp • Jan. 27, 2022
  • Image attribution tooltip
    400tmax via Getty Images
    Image attribution tooltip

    The shifting digital health investment landscape in 2022

    Signs point toward another historic year in VC investment, experts say, which will benefit the medical system as it evolves to include more digital services.

    Rebecca Pifer • Jan. 25, 2022
  • Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip

    Medical device security continues to be casualty of hospital-medtech divide

    FDA says manufacturers and hospitals are both responsible for protecting devices from growing cybersecurity threats. However, experts say healthcare providers carry a much heavier load.

    Greg Slabodkin • Dec. 1, 2021
  • Image attribution tooltip
    Adeline Kon/Healthcare Dive/MedTech Dive
    Image attribution tooltip

    Why are women more likely to use telehealth?

    As Washington mulls over telehealth regulations post-COVID-19, it's important not to roll back access in a way that could disproportionately affect women, experts say.

    Rebecca Pifer • Nov. 3, 2021
  • Anatomy of a medical device recall: How defective products can slip through an outdated system

    "It truly is like we are operating in about the 1950s," one consultant noted of the process. The FDA has held two meetings in the past year to mull improvements.

    Ricky Zipp • Oct. 18, 2021
  • Image attribution tooltip
    Michael Nagle via Getty Images
    Image attribution tooltip

    How Morgan Health hopes to finally move the needle on employer health costs: 5 insights from a chat with the venture's CEO

    Morgan Health learned a lot from Haven, but is a different beast with better knowledge of the buy-in needed to disrupt the health benefits space, CEO Dan Mendelson told Healthcare Dive.

    Rebecca Pifer • Oct. 8, 2021
  • Image attribution tooltip
    Sean Gallup via Getty Images
    Image attribution tooltip

    Will a software bill of materials help or hurt medical device cybersecurity?

    President Joe Biden's executive order calls for SBOMs, and the FDA wants to require premarket submissions to have an inventory of third-party device components. AdvaMed is concerned the data could be exploited by hackers.

    Greg Slabodkin • Oct. 7, 2021
  • Medtechs are boosting DTC investment, but industry still years behind pharma

    Companies are spending hundreds of millions of dollars every year on direct-to-consumer advertising as the industry focuses on marketing more to patients.

    Ricky Zipp • Sept. 14, 2021
  • HIMSS21 header photo for health conference news
    Image attribution tooltip
    Adeline Kon/MedTech Dive
    Image attribution tooltip

    Predicting the future of healthcare: 10 takeaways from HIMSS21

    Along with "guarded optimism" on the current state of the pandemic, some 19,000 on-site attendees in Las Vegas mulled what's next for AI, telehealth, cybersecurity, mental health and more.

    Rebecca Pifer and Hailey Mensik • Aug. 17, 2021
  • People of color work together in an office
    Image attribution tooltip

    Photo by Fauxels (Studio) from Pexels

    Image attribution tooltip

    Medtech industry starts to face lack of diversity, execs of color

    AdvaMed contends the percentage of Black people in leadership roles at device companies has more than doubled from 1.3% to 3.2% since 2015. However, currently none of the largest medtechs has a CEO of color.

    Greg Slabodkin • Aug. 12, 2021
  • Diabetes tech companies set sights on Type 2 patients as user numbers climb

    With patients flocking to CGMs and insulin pumps over the past several years, companies like Dexcom, Insulet and Tandem are looking to further expand. 

    Ricky Zipp • Aug. 9, 2021
  • Medtech M&A expected to be robust in second half after 2021 began with a flurry

    Even after deals already eclipsed last year's numbers, analysts predict robust activity in particular among diagnostics companies flush with cash from 2020's COVID-19 test sales.

    Ricky Zipp • July 18, 2021
  • a picture of a red stethoscope on top of a US billed money.
    Image attribution tooltip
    Adeline Kon/Healthcare Dive/MedTech Dive
    Image attribution tooltip

    Medtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell

    Zimmer Biomet had the biggest drop, cutting general payments nearly 80% to $63 million. Other notable decreases include Stryker, J&J's DePuy Synthes and Boston Scientific.

    Ricky Zipp • July 12, 2021
  • Legacy medical devices, growing hacker threats create perfect storm of cybersecurity risks

    Aging medtech and increasingly sophisticated criminals are leaving hospitals highly vulnerable to attacks.

    Greg Slabodkin • June 22, 2021
  • Medtronic HeartWare system hit with slew of Class I recalls, device reports since 2012 PMA

    The pump has a higher rate of malfunction reports than rivals, according to an ECRI analysis of the FDA's MAUDE database. But it's hard to draw conclusions from a disparate system of safety reporting.

    Ricky Zipp • May 21, 2021
  • Virtual proctoring, training poised to be new normal in post-pandemic surgical interactions

    Prior to the COVID-19 public health crisis, momentum to transition operating rooms into digitally connected learning environments was building. Social distancing mandates accelerated those efforts.  

    Greg Slabodkin • May 19, 2021
  • Medtronic's robotic spine market lead threatened as smaller rivals look to edge in

    Medtronic and Globus Medical are currently in a "two pony race" in the space, but market share can be stolen as other companies launch systems and adoption grows.

    Ricky Zipp • April 9, 2021
  • Image attribution tooltip
    Robotic Surgery/MedTech Dive
    Image attribution tooltip

    Robotics demand held firm as pandemic pummeled electives

    Intuitive Surgical, Stryker and Zimmer Biomet all saw procedure volumes drop in 2020 as electives shut down. However, system demand remained strong despite the financial hit to hospitals.

    Ricky Zipp • March 18, 2021
  • Members of the Army and Air National Guard from across several states have been activated under Operation COVID-19 to support federal, state and local efforts. (
    Image attribution tooltip
    The image by The National Guard is licensed under CC BY 2.0
    Image attribution tooltip

    From labs to homes: where COVID-19 testing is headed in 2021

    The U.S. appears to have reached a new phase in its battle against the coronavirus with vaccinations taking precedence over tests. Whether testing will return to earlier levels is an open question.

    Greg Slabodkin • March 17, 2021
  • Image attribution tooltip
    Adeline Kon/MedTech Dive
    Image attribution tooltip

    All eyes on elective care after a rollercoaster year for medtech

    After shutdowns slammed procedure-dependent firms in 2020, industry and Wall Street are waiting to see when non-emergency surgeries return and what a comeback might look like.

    Ricky Zipp • March 16, 2021